Literature DB >> 10227644

FK506-induced leukoencephalopathy in children with organ transplants.

H V Torocsik1, R G Curless, J Post, A G Tzakis, L Pearse.   

Abstract

FK506-induced leukoencephalopathy is a well-known entity in adult organ transplant patients. The neurotoxicity of FK506 immunosuppression is frequently reversible, with either reduction or cessation of the drug. This neurologic syndrome is not well documented in children. We report the clinical and radiologic features in four pediatric cases of FK506 leukoencephalopathy. In two of the four patients this syndrome was reversible.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10227644     DOI: 10.1212/wnl.52.7.1497

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  3 in total

1.  Severe tacrolimus leukoencephalopathy after liver transplantation.

Authors:  Janneke Schuuring; Pieter Wesseling; Aad Verrips
Journal:  AJNR Am J Neuroradiol       Date:  2003 Nov-Dec       Impact factor: 3.825

2.  Progressive neurological disease induced by tacrolimus in a renal transplant recipient: case presentation.

Authors:  Marjan Chegounchi; Michael G Hanna; Guy H Neild
Journal:  BMC Nephrol       Date:  2006-03-31       Impact factor: 2.388

3.  Posterior reversible encephalopathy syndrome in a postpartum hemorrhagic woman without hypertension: A case report.

Authors:  Chon-Fu Lio; Ying-Hua Lee; Hung-Yen Chan; Chang-Ching Yu; Nan-Jing Peng; Hung-Pin Chan
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.